SCHEMBL7013440

SCHEMBL7013440

CC(=O)Nc1ccc(C(=O)NC(CC(C)(C)C)C(=O)N(C)C2(C#N)CCNCC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSL P07711 6/20 0.40
CTSS P25774 3/20 0.37
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
CTSB P07858 4/20 0.34
CTSK P43235 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NFKB1 P19838 1/20 0.33
KCNH2 Q12809 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
NAMPT P43490 1/20 0.33
NPC1 O15118 1/20 0.32
POLB P06746 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423676 0.88 CTSL (0.44) CTSLCTSSCTSBCTSKRAB9A
SCHEMBL7414894 0.84 CTSS (0.45) CTSLCTSSCTSBCTSK
SCHEMBL7021242 0.76 CTSL (0.39) CTSLCTSSCTSBCTSKKCNH2
SCHEMBL7415423 0.74 CTSS (0.43) CTSLCTSSCTSBCTSK
SCHEMBL5365706 0.73 CTSL (0.50) CTSLCTSSCTSBCTSK
SCHEMBL7414674 0.72 CTSS (0.45) CTSLCTSSCTSBCTSKKMT2A
SCHEMBL7419241 0.72 CTSL (0.43) CTSLCTSSCTSBCTSKALDH1A1
SCHEMBL7410718 0.72 CTSS (0.47) CTSLCTSSCTSBCTSKMEN1
SCHEMBL7417185 0.72 CTSL (0.57) CTSLCTSSCTSBCTSK
SCHEMBL5360291 0.72 CTSS (0.51) CTSLCTSSCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003529546-A 2003-10-07 JP claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP claimed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed